Cagrilintide/semaglutide
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglu
Novo Nordisk · Phase 2 · Completed · Enrollment 626
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.